HOOKIPA PHARMA INC's ticker is HOOK and the CUSIP is 43906K100. A total of 55 filers reported holding HOOKIPA PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,352 | -30.0% | 36,285 | 0.0% | 0.00% | – |
| Q2 2023 | $31,931 | +19.6% | 36,285 | 0.0% | 0.00% | – |
| Q1 2023 | $26,706 | -9.1% | 36,285 | 0.0% | 0.00% | – |
| Q4 2022 | $29,391 | -40.0% | 36,285 | 0.0% | 0.00% | – |
| Q3 2022 | $49,000 | -47.3% | 36,285 | -10.8% | 0.00% | – |
| Q1 2022 | $93,000 | -17.0% | 40,694 | -14.7% | 0.00% | – |
| Q4 2021 | $112,000 | -60.1% | 47,694 | 0.0% | 0.00% | – |
| Q3 2021 | $281,000 | -35.7% | 47,694 | 0.0% | 0.00% | – |
| Q2 2021 | $437,000 | -14.0% | 47,694 | +26.4% | 0.00% | – |
| Q1 2021 | $508,000 | +40.3% | 37,735 | +15.8% | 0.00% | – |
| Q4 2020 | $362,000 | +17.2% | 32,591 | 0.0% | 0.00% | – |
| Q3 2020 | $309,000 | -1.0% | 32,591 | +21.6% | 0.00% | – |
| Q2 2020 | $312,000 | +77.3% | 26,791 | +25.7% | 0.00% | – |
| Q1 2020 | $176,000 | -32.6% | 21,321 | 0.0% | 0.00% | – |
| Q4 2019 | $261,000 | – | 21,321 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,842,902 | $17,452,000 | 0.32% |
| Samsara BioCapital, LLC | 116,602 | $1,104,000 | 0.31% |
| Artal Group S.A. | 599,616 | $5,678,000 | 0.14% |
| HHLR ADVISORS, LTD. | 943,254 | $8,933,000 | 0.07% |
| DAFNA Capital Management LLC | 22,061 | $209,000 | 0.07% |
| Baker Brothers Advisors | 700,481 | $6,634,000 | 0.03% |
| ZACKS INVESTMENT MANAGEMENT | 72,064 | $682,000 | 0.01% |
| HOWLAND CAPITAL MANAGEMENT LLC | 14,728 | $139,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 14,374 | $139,000 | 0.00% |
| Squarepoint Ops LLC | 12,699 | $120,000 | 0.00% |